-
These Pharma Companies Join Forces To Bring Medical Cannabis Products To Czech & Swiss Markets
Thursday, October 6, 2022 - 7:46am | 476Read More...Panaxia (TASE: PNAX), a cannabis-focused pharmaceutical company and European specialty pharmaceutical company Neuraxpharm Group announced on Thursday the signing of two addendums to their agreement to expand their collaboration into the Czech and Swiss markets. What Happened? The collaboration...
-
Panaxia Confirms First Export Of Medical Cannabis Sublingual Tablets To France
Monday, January 24, 2022 - 9:43am | 532Read More...Cannabis-focused pharma company Panaxia Labs Israel (TASE:PNAX) (OTCEM:PXLIF) and a subsidiary of Panaxia Global, together with Neuraxpharm Group announced Monday a first export of medical cannabis sublingual tablets from Israel to France. Neuraxpharm is a European specialty pharmaceutical company...
